HKD 0.79
(-4.82%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 237.35 Million | 211.99 Million | 119.35 Million | 78.56 Million | 47.59 Million | 1.26 Million |
Net Income | 148.76 Million | 85.2 Million | 39.47 Million | 17.68 Million | 32.85 Million | 25.67 Million |
Depreciation & Amortization | 44.81 Million | 38.47 Million | 34.86 Million | 28.73 Million | 21.41 Million | 18.84 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 30.36 Million | 64.35 Million | 34.71 Million | 24.48 Million | -698 Thousand | -45.06 Million |
Other non-cash items | 14.6 Million | 23.95 Million | 10.3 Million | 7.65 Million | -5.97 Million | 1.8 Million |
Investing Cash Flow | -140.99 Million | -153.36 Million | -76.65 Million | -95.95 Million | -382.16 Million | -49.37 Million |
Investments in PPE | -141 Million | -153.36 Million | -81.65 Million | -120.95 Million | -538.36 Million | -76.39 Million |
Acquisitions | - | - | - | - | - | 13.61 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.3 Million | 2000.00 | 5 Million | 25 Million | 156.2 Million | 13.39 Million |
Financing Cash Flow | -81.75 Million | -19.67 Million | -37.75 Million | -54.03 Million | 447.27 Million | 86.96 Million |
Debt repayment | -60.74 Million | -94.56 Million | -58.66 Million | -104.29 Million | -150.08 Million | -15.6 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -13.73 Million | -3.48 Million |
Common Stock Issuance | - | - | - | - | 155.57 Million | - |
Other Financing Activities | -20.41 Million | 74.89 Million | 20.9 Million | 50.25 Million | 455.51 Million | 106.04 Million |
Accounts receivables | 11.53 Million | -12.92 Million | -94 Thousand | 1.29 Million | -1.41 Million | 898 Thousand |
Accounts payables | - | 12.92 Million | 94 Thousand | -1.29 Million | - | - |
Inventory | -144 Thousand | -747 Thousand | 25 Thousand | -380 Thousand | - | - |
Other working capital | -2.65 Million | 65.1 Million | 34.69 Million | 24.86 Million | 713 Thousand | -50.49 Million |
Cash at beginning of period | 199.85 Million | 156.3 Million | 152.52 Million | 227.51 Million | 114.81 Million | 75.96 Million |
Cash at end of period | 215.71 Million | 199.85 Million | 156.3 Million | 152.52 Million | 227.51 Million | 114.81 Million |
Capital Expenditure | -141 Million | -153.36 Million | -81.65 Million | -120.95 Million | -538.36 Million | -76.39 Million |
Effect of forex changes on cash | 1.24 Million | 4.59 Million | -1.16 Million | -3.56 Million | 1.54 Million | - |
Net cash flow / Change in cash | 15.85 Million | 43.54 Million | 3.77 Million | -74.99 Million | 112.7 Million | 38.84 Million |
Free Cash Flow | 96.35 Million | 58.62 Million | 37.69 Million | -42.39 Million | -490.77 Million | -75.12 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 53.31 Million | 53.31 Million | 32.93 Million | 148.76 Million | 32.93 Million | 41.07 Million |
Depreciation & Amortization | 10.54 Million | 10.54 Million | 11.64 Million | 44.81 Million | 11.51 Million | 10.64 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 4.36 Million | 30.36 Million | 4.36 Million | - |
Other non-cash items | -102.53 Million | -102.53 Million | 102.16 Million | 14.6 Million | 102.3 Million | -84.16 Million |
Investing Cash Flow | -31.49 Million | -31.49 Million | -45.11 Million | -140.99 Million | -45.11 Million | -25.38 Million |
Investments in PPE | -31.13 Million | -31.13 Million | -44.56 Million | -141 Million | -44.56 Million | -25.28 Million |
Acquisitions | - | - | - | - | - | 3392.86 |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -362 Thousand | -362 Thousand | -556 Thousand | -1.3 Million | -556 Thousand | -96.5 Thousand |
Financing Cash Flow | -489.5 Thousand | -489.5 Thousand | -21.63 Million | -81.75 Million | -21.63 Million | -19.23 Million |
Debt repayment | - | - | - | -60.74 Million | - | -28.52 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -489.5 Thousand | -489.5 Thousand | -21.63 Million | -20.41 Million | -21.63 Million | -19.23 Million |
Accounts receivables | - | - | 5.76 Million | 11.53 Million | 5.76 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | -72 Thousand | -144 Thousand | -72 Thousand | - |
Other working capital | - | - | -1.32 Million | -2.65 Million | -1.32 Million | - |
Cash at beginning of period | - | - | - | 199.85 Million | - | 224.38 Million |
Cash at end of period | -70.68 Million | -70.68 Million | 84.21 Million | 215.71 Million | 84.21 Million | 51.02 Million |
Capital Expenditure | -31.13 Million | -31.13 Million | -44.56 Million | -141 Million | -44.56 Million | -25.28 Million |
Effect of forex changes on cash | -18.5 Thousand | -18.5 Thousand | -156 Thousand | 1.24 Million | -156 Thousand | 778.5 Thousand |
Net cash flow / Change in cash | -70.68 Million | -70.68 Million | 84.21 Million | 15.85 Million | 84.21 Million | -173.36 Million |
Free Cash Flow | -69.81 Million | -69.81 Million | 106.56 Million | 96.35 Million | 106.56 Million | -57.72 Million |
BEM
CDLR
3803
IVCGF
DALBHARAT
VAXX